Senator Spilka Honored by Biotechnology
by Press Release 6/29/12
(Senator Spilka Accepts 2012 State Legislator of the Year Award at BIO 2012.)
On Monday, June 18th, I was honored to be recognized by the Biotechnology Industry Organization (BIO) as one of their State Legislators of the Year at the 2012 BIO International Convention held last week at the Boston Convention & Exhibition Center.
On Monday, June 18th, I was honored to be recognized by the Biotechnology Industry Organization (BIO) as one of their State Legislators of the Year at the 2012 BIO International Convention held last week at the Boston Convention & Exhibition Center. I am grateful to the Massachusetts Biotechnology Council and the many life science leaders who nominated me for this award.
The life science industry is one of the pillars of the Massachusetts economy and an important employer right here in MetroWest. In my time in the Senate I have worked closely with companies, educators and local officials to support the partnerships necessary for this important industry cluster to thrive in our state. Our efforts to support a well educated and trained workforce and encourage companies to locate here have made Massachusetts the global leader in biotechnology. The evidence of our success was on display at BIO’s largest convention ever.
As always, please do not hesitate to reach out to me at (617) 722-1640 or by email at Karen.Spilka@masenate.gov with any questions you may have or if I can be of any assistance to you.
The Massachusetts Pavilion at BIO 2012 presented a compelling picture of how all stakeholders in our supercluster – including government – come together in service to heal patients facing overwhelming challenges. This year’s theme, Lifecycle Massachusetts, illustrated how Massachusetts life sciences organizations span the spectrum of healthcare. From training and education, through research and discovery, and right on to manufacturing and delivery of treatment – this lifecycle is possible thanks to the community and cooperation unique to the Massachusetts.
The Pavilion highlighted the individuals and companies who are in the forefront of the industry – including many MetroWest employers. It was a great way to help spread the word about the groundbreaking work happening in our state.
The first round of grants under the Massachusetts-Israeli Innovation Partnership (MIIP) was announced on Tuesday, June 19th at the Massachusetts Pavilion at BIO 2012. One of the companies selected was Natick-based SBH Sciences, an innovative discovery and preclinical contract research organization, focused on anti-cancer and anti-inflammation drug development. SBH Sciences will work with Israel-based company, Improdia to develop and manufacture a chronic inflammation-dependent immunosuppression prognostic kit.
Congratulations to SBH Sciences and the other companies selected for this first round of grants. I look forward to seeing the impacts these important international collaborations will have on the care of our patients, our economy, and job creation.